Pfizer Inc. (PFE)

NYSE: PFE · Real-Time Price · USD

23.91

-0.50 (-2.05%)

At close: May 01, 2025, 3:59 PM

23.88

-0.15%

After-hours: May 01, 2025, 04:08 PM EDT

Pfizer Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	1.04B	2.85B	416M	1.94B	1.78B	1.3B	1.14B	1.34B	2.6B
Short-Term Investments	19.43B	9.84B	22.32B	29.13B	10.44B	8.53B	17.69B	18.65B	15.26B
Long-Term Investments	2.23B	15.77B	15.07B	21.53B	20.26B	20.15B	2.77B	7.01B	7.12B
Other Long-Term Assets	9.82B	9.14B	13.16B	7.68B	4.57B	4.45B	2.8B	3.23B	3.32B
Receivables	14.78B	11.18B	10.95B	11.48B	7.91B	6.77B	8.03B	8.22B	8.22B
Inventory	10.85B	10.19B	8.98B	9.06B	8.05B	8.28B	7.51B	7.58B	6.78B
Other Current Assets	4.25B	9.28B	8.59B	8.09B	6.91B	9.32B	15.56B	5.34B	6.09B
Total Current Assets	50.36B	43.33B	51.26B	59.69B	35.07B	32.8B	49.93B	41.14B	38.95B
Property-Plant & Equipment	18.39B	21.86B	16.27B	14.88B	13.9B	13.97B	13.38B	13.87B	13.32B
Goodwill & Intangibles	123.94B	132.68B	94.75B	74.35B	78.05B	94.02B	88.62B	104.69B	107.1B
Total Long-Term Assets	163.04B	183.17B	145.94B	121.78B	119.16B	134.69B	109.5B	130.65B	132.67B
Total Assets	213.4B	226.5B	197.21B	181.48B	154.23B	167.49B	159.42B	171.8B	171.62B
Account Payables	5.63B	6.71B	6.81B	5.58B	4.28B	3.89B	4.67B	4.66B	4.54B
Deferred Revenue	1.51B	2.7B	2.52B	3.07B	6.27B	5.8B	5.71B	4.7B	4.87B
Short-Term Debt	6.95B	10.35B	2.94B	2.24B	2.7B	16.46B	8.84B	9.95B	10.69B
Other Current Liabilities	23.56B	25.69B	24.87B	30.52B	14.61B	13.58B	12.64B	13.14B	12.97B
Total Current Liabilities	42.99B	47.79B	42.14B	42.67B	25.92B	37.3B	31.86B	30.43B	31.11B
Long-Term Debt	56.7B	61.54B	31.93B	34.76B	37.13B	35.95B	32.43B	33.54B	31.4B
Other Long-Term Liabilities	23.08B	27.24B	26.2B	26.24B	23.64B	5.29B	5.85B	5.28B	6.34B
Total Long-Term Liabilities	81.9B	89.42B	59.15B	61.34B	64.84B	66.74B	63.81B	69.71B	80.66B
Total Liabilities	124.9B	137.21B	101.29B	104.01B	90.76B	104.04B	95.66B	100.14B	111.78B
Total Debt	63.65B	70.84B	34.87B	37B	38.27B	52.15B	41.27B	42.61B	42.09B
Common Stock	480M	478M	476M	473M	470M	468M	467M	464M	461M
Retained Earnings	116.72B	118.35B	125.66B	103.39B	96.77B	97.67B	89.55B	85.29B	71.77B
Comprehensive Income	-7.84B	-7.96B	-8.3B	-5.9B	-11.69B	-11.64B	-11.28B	-9.32B	-11.04B
Shareholders Equity	88.2B	89.01B	95.66B	77.2B	63.24B	63.14B	63.41B	71.31B	59.54B
Total Investments	21.66B	25.2B	37.38B	50.65B	30.7B	28.67B	20.46B	25.66B	22.37B